Comparing exercise capacities and muscle oxygenation in patients with interstitial lung disease
Comparison of Upper and Lower Limb Maximal Exercise Capacities, Muscle Oxygenation and Energy Consumption During Tests in Patients With Interstitial Lung Disease
This study looks at how interstitial lung disease affects exercise ability and muscle oxygen levels in patients to help improve their rehabilitation.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 30 (estimated) |
| Ages | 18 Years to 75 Years |
| Sex | All |
| Sponsor | Gazi University Academic / other |
| Locations | 1 site (Ankara, Çankaya) |
| Trial ID | NCT06141603 on ClinicalTrials.gov |
What this trial studies
This observational study aims to compare the maximal exercise capacities and muscle oxygenation levels of patients with interstitial lung disease (ILD). It focuses on understanding how ILD affects both upper and lower limb exercise performance and the underlying physiological mechanisms. By assessing cardiopulmonary exercise testing results, the study seeks to identify differences in exercise capacity and muscle strength between the upper and lower extremities in these patients. The findings may help in tailoring rehabilitation strategies for individuals suffering from ILD.
Who should consider this trial
Good fit: Ideal candidates for this study are adults aged 18-75 diagnosed with interstitial lung disease.
Not a fit: Patients with acute infections, orthopedic or neurological diseases affecting exercise capacity, or recent COVID-19 infections may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved rehabilitation strategies that enhance exercise capacity and quality of life for patients with interstitial lung disease.
How similar studies have performed: Other studies have shown varying success in understanding exercise capacities in ILD, but this specific comparative approach is less commonly explored.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * patients between the ages of 18-75 with interstitial lung disease Exclusion Criteria: * acute infection during the study * have an orthopedic or neurological disease that will affect their exercise capacity * acute exacerbation or any infection * have contraindications to the exercise test * an acute respiratory infection * had Coronavirus-19 (COVID-19) disease in the last 3 months * have undergone different treatments other than standard medical treatment
Where this trial is running
Ankara, Çankaya
- Gazi University, Faculty of Health Sciences, Department of Physiotherapy and Rehabilitation, Cardiopulmonary Rehabilitation Unit — Ankara, Çankaya, Turkey (Recruiting)
Study contacts
- Principal investigator: Beyza Nur ÖYMEZ, Pt. — Gazi University
- Study coordinator: Meral BOŞNAK GÜÇLÜ, Prof. Dr.
- Email: meralbosnak@gazi.edu.tr
- Phone: 03122162647
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.